ClinicalTrials.govpublic full text
Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer
esophageal cancer, oesophageal cancer, oesophageal adenocarcinoma, oesophageal squamous cell carcinoma, immunotherapy, cytotoxic t-lymphocyte-associated protein 4 (ctla-4), programmed cell death protein 1 (pd-1), programmed death ligand 1 (pd-l1), interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 825854
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.